X-8170037-C-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_016378.3(VCX2):ā€‹c.415G>Cā€‹(p.Asp139His) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000054 ( 0 hom., 1 hem., cov: 13)
Exomes š‘“: 0.000061 ( 1 hom. 24 hem. )
Failed GnomAD Quality Control

Consequence

VCX2
NM_016378.3 missense

Scores

4
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.15
Variant links:
Genes affected
VCX2 (HGNC:18158): (variable charge X-linked 2) This gene belongs to the VCX/Y gene family, which has multiple members on both X and Y chromosomes that are expressed exclusively in male germ cells. The VCX gene cluster is polymorphic in terms of copy number; different individuals may have a different number of VCX genes. This gene contains two copies of a 30 nt tandem repeat. Deletion of a nearby member of this family was implicated in cognitive disability. [provided by RefSeq, Feb 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07181105).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
VCX2NM_016378.3 linkuse as main transcriptc.415G>C p.Asp139His missense_variant 3/3 ENST00000317103.5 NP_057462.2
LOC107985675XR_001755783.2 linkuse as main transcriptn.1915-58298C>G intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
VCX2ENST00000317103.5 linkuse as main transcriptc.415G>C p.Asp139His missense_variant 3/31 NM_016378.3 ENSP00000321309 P1
ENST00000659022.1 linkuse as main transcriptn.972-58298C>G intron_variant, non_coding_transcript_variant
ENST00000649338.1 linkuse as main transcriptn.263-58298C>G intron_variant, non_coding_transcript_variant

Frequencies

GnomAD3 genomes
AF:
0.0000544
AC:
5
AN:
91839
Hom.:
0
Cov.:
13
AF XY:
0.0000578
AC XY:
1
AN XY:
17305
show subpopulations
Gnomad AFR
AF:
0.0000410
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000860
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000331
AC:
6
AN:
181495
Hom.:
0
AF XY:
0.0000445
AC XY:
3
AN XY:
67415
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000746
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000611
AC:
67
AN:
1096478
Hom.:
1
Cov.:
31
AF XY:
0.0000661
AC XY:
24
AN XY:
362828
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000284
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000784
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000544
AC:
5
AN:
91839
Hom.:
0
Cov.:
13
AF XY:
0.0000578
AC XY:
1
AN XY:
17305
show subpopulations
Gnomad4 AFR
AF:
0.0000410
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000860
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.000125
ExAC
AF:
0.0000415
AC:
5
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000594

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 26, 2023The c.415G>C (p.D139H) alteration is located in exon 3 (coding exon 2) of the VCX2 gene. This alteration results from a G to C substitution at nucleotide position 415, causing the aspartic acid (D) at amino acid position 139 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.37
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.81
CADD
Benign
6.0
DANN
Benign
0.74
DEOGEN2
Benign
0.0039
T
FATHMM_MKL
Benign
0.0072
N
LIST_S2
Benign
0.30
T
M_CAP
Benign
0.0014
T
MetaRNN
Benign
0.072
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.69
N
MutationTaster
Benign
1.0
N
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
0.11
N
REVEL
Benign
0.059
Sift
Uncertain
0.0040
D
Sift4G
Uncertain
0.013
D
Polyphen
0.99
D
Vest4
0.19
MutPred
0.17
Gain of glycosylation at T138 (P = 0.0711);
MVP
0.014
MPC
0.0089
ClinPred
0.068
T
GERP RS
0.19
Varity_R
0.099
gMVP
0.0040

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs145708656; hg19: chrX-8138078; API